Informing on health and wellness news in Djibouti

Provided by AGP

Djibouti Health Journal
Got News to Share?
Got News to Share? Explore more publications!

Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 1, 2026

Nova Leap Health Corp. announces Closing of Strategic Acquisition in Nova Scotia
May. 1, 2026

Nova Leap Health Corp. announces Closing of Strategic Acquisition in Nova Scotia

Indeterminate GlobeNewswire
InflaRx to Report First Quarter 2026 Results on May 7, 2026
May. 1, 2026

InflaRx to Report First Quarter 2026 Results on May 7, 2026

Indeterminate GlobeNewswire
Axsome Therapeutics Hosts AUVELITY® FDA Approval Investor Event Featuring Expert Thought Leader
May. 1, 2026

Axsome Therapeutics Hosts AUVELITY® FDA Approval Investor Event Featuring Expert Thought Leader

Indeterminate GlobeNewswire
Noema Pharma to Present Phase 2a Results for Cendifensine in Vasomotor Symptoms (Hot Flashes) Due to Menopause at the 2026 ACOG Annual Clinical & Scientific Meeting
May. 1, 2026

Noema Pharma to Present Phase 2a Results for Cendifensine in Vasomotor Symptoms (Hot Flashes) Due to Menopause at the 2026 ACOG Annual Clinical & Scientific Meeting

Indeterminate GlobeNewswire
Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling
May. 1, 2026

Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling

Indeterminate GlobeNewswire
MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results
May. 1, 2026

MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results

Indeterminate GlobeNewswire
Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC)
May. 1, 2026

Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC)

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity
May. 1, 2026

Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity

Indeterminate GlobeNewswire
Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution
May. 1, 2026

Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution

Indeterminate GlobeNewswire
BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance
May. 1, 2026

BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance

Indeterminate GlobeNewswire
Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
May. 1, 2026

Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Indeterminate GlobeNewswire
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026
May. 1, 2026

Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026

Indeterminate GlobeNewswire
MemoPryl Under Investigation (2026 Official Website Scam WARNING Update) Avoid Fake Complaints & Hidden Risks
May. 1, 2026

MemoPryl Under Investigation (2026 Official Website Scam WARNING Update) Avoid Fake Complaints & Hidden Risks

Indeterminate GlobeNewswire
Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
May. 1, 2026

Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire
SteelPower Capsules for Male Enhancement Support: Review the Ingredients & Where to Buy to Avoid Complaints
May. 1, 2026

SteelPower Capsules for Male Enhancement Support: Review the Ingredients & Where to Buy to Avoid Complaints

Indeterminate GlobeNewswire
Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock
May. 1, 2026

Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn

Sign up for:

Djibouti Health Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.